psoriasis

Graphic of two hands shaking under a red and purple light
Biotech

Fosun pays $32M to join Lilly and Novartis in psoriasis market

A Fosun Pharma subsidiary has paid Junshi Biosciences $32 million for Chinese rights to a near-approval autoimmune disease drug candidate.
Nick Paul Taylor Jul 2, 2026 8:30am
head to head against clash football helmets fight combat

Takeda’s TYK2 inhibitor beats BMS’ Sotyktu in psoriasis showdown

Jun 11, 2026 7:00am
Graphic image of an arrow nailing the bullseye of a target

Oruka’s psoriasis data hailed as ‘outright win over Skyrizi’

Apr 27, 2026 9:51am
one white and yellow capsule farther ahead than four other same-colored blue capsules

Takeda clears path to FDA with phase 3 data on $4B psoriasis bet

Mar 28, 2026 3:00pm
A ballpoint pen rests on top of a stack of documents ready for signing

China biotech inks $135M deal for remaining rights to vTv med

Feb 2, 2026 10:10am
Graphic image of an arrow nailing the bullseye of a target

Alumis beams as pivotal data on Sotyktu rival drive stock surge

Jan 6, 2026 9:05am